Viitai NCST helps  biotech companies or Contract Research Organizations (CROs) stay on top of their nonclinical studies and sub-studies management with one simple tool that enables clients reach IND/CTA status sooner.

SOUTH SAN FRANCISCO, CA – Feb. 4, 2020 – Viitai today announced the release of the latest version of Nonclinical Study Tracker (NCST), a secure cloud solution for nonclinical study management.

Traditionally biotech companies or CROs use a combination of various tools to manage different aspects of nonclinical studies. This creates resource usage inefficiency and slows down progress  towards IND/CTA filing. The majority of existing tools are also non-compliant with FDA regulations creating compliance risk and exposure. The new version of the NCST solution allows all parties (e.g., sponsors and CROs) involved in nonclinical studies management to work on one single and easy to use platform to gain real-time insights into study status across drug programs. With the new NCST solution, clients won’t miss upcoming milestones or need to worry about audits since the solution is audit ready.

“Viitai aims to simplify the management of all aspects related to nonclinical studies”, said Jeff Cao, CEO of Viitai. “We are proud to partner with Microsoft and the life science community to deliver a solution that offers clients significant efficiency improvements while providing full compliance with regulations.”

The Viitai NCST cloud solution is an “off-the-shelf” product ready for immediate deployment. It requires no maintenance effort in client side.

About Viitai

Viitai is a leading software company committed to developing and bringing the best quality applications specifically to life science organizations. Founded in 2012, the company has built a portfolio of apps that are efficient, standard aligned, regulatory filing driven, scalable, and compliant with regulations.

Contact

Jeff Cao

[email protected] or

James Wood

[email protected]